186 related articles for article (PubMed ID: 2458038)
1. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.
Furlong CE; Richter RJ; Seidel SL; Motulsky AG
Am J Hum Genet; 1988 Sep; 43(3):230-8. PubMed ID: 2458038
[TBL] [Abstract][Full Text] [Related]
2. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.
Furlong CE; Richter RJ; Seidel SL; Costa LG; Motulsky AG
Anal Biochem; 1989 Aug; 180(2):242-7. PubMed ID: 2479288
[TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats.
Costa LG; McDonald BE; Murphy SD; Omenn GS; Richter RJ; Motulsky AG; Furlong CE
Toxicol Appl Pharmacol; 1990 Mar; 103(1):66-76. PubMed ID: 1690462
[TBL] [Abstract][Full Text] [Related]
4. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
Mutch E; Daly AK; Williams FM
Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
[TBL] [Abstract][Full Text] [Related]
5. The human serum paraoxonase/arylesterase polymorphism.
Eckerson HW; Wyte CM; La Du BN
Am J Hum Genet; 1983 Nov; 35(6):1126-38. PubMed ID: 6316781
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase status: a major factor in determining resistance to organophosphates.
Li WF; Costa LG; Furlong CE
J Toxicol Environ Health; 1993; 40(2-3):337-46. PubMed ID: 7693961
[TBL] [Abstract][Full Text] [Related]
7. Serum albumin is as efficient as paraxonase in the detoxication of paraoxon at toxicologically relevant concentrations.
Sogorb MA; García-Argüelles S; Carrera V; Vilanova E
Chem Res Toxicol; 2008 Aug; 21(8):1524-9. PubMed ID: 18597495
[TBL] [Abstract][Full Text] [Related]
8. Purification of two rat hepatic proteins with A-esterase activity toward chlorpyrifos-oxon and paraoxon.
Pond AL; Chambers HW; Coyne CP; Chambers JE
J Pharmacol Exp Ther; 1998 Sep; 286(3):1404-11. PubMed ID: 9732404
[TBL] [Abstract][Full Text] [Related]
9. Serum paraoxonase polymorphism in three populations of southeast Asia.
Roy AC; Saha N; Tay JS; Ratnam SS
Hum Hered; 1991; 41(4):265-9. PubMed ID: 1664414
[TBL] [Abstract][Full Text] [Related]
10. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism.
La Du BN; Piko JI; Eckerson HW; Vincent-Viry M; Siest G
Ann Biol Clin (Paris); 1986; 44(4):369-72. PubMed ID: 3024532
[TBL] [Abstract][Full Text] [Related]
11. Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.
Ortigoza-Ferado J; Richter RJ; Hornung SK; Motulsky AG; Furlong CE
Am J Hum Genet; 1984 Mar; 36(2):295-305. PubMed ID: 6324579
[TBL] [Abstract][Full Text] [Related]
12. The PON1 gene and detoxication.
Furlong CE; Li WF; Brophy VH; Jarvik GP; Richter RJ; Shih DM; Lusis AJ; Costa LG
Neurotoxicology; 2000 Aug; 21(4):581-7. PubMed ID: 11022865
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase polymorphism in rabbits.
Zech R; Severin RM; Chemnitius JM; Nebendahl K
Chem Biol Interact; 1999 May; 119-120():283-8. PubMed ID: 10421463
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis of the human serum paraoxonase activity polymorphism.
Humbert R; Adler DA; Disteche CM; Hassett C; Omiecinski CJ; Furlong CE
Nat Genet; 1993 Jan; 3(1):73-6. PubMed ID: 8098250
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the serum paraoxonase/arylesterase polymorphism in a Turkish population.
Karakaya A; Suzen S; Sardas S; Karakaya AE; Vural N
Pharmacogenetics; 1991 Oct; 1(1):58-61. PubMed ID: 1668963
[TBL] [Abstract][Full Text] [Related]
16. Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase.
Rodrigo L; Gil F; Hernández AF; Pla A
Chem Biol Interact; 1999 May; 119-120():263-75. PubMed ID: 10421461
[TBL] [Abstract][Full Text] [Related]
17. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies.
Mueller RF; Hornung S; Furlong CE; Anderson J; Giblett ER; Motulsky AG
Am J Hum Genet; 1983 May; 35(3):393-408. PubMed ID: 6305189
[TBL] [Abstract][Full Text] [Related]
18. The polymorphic paraoxonase/arylesterase isozymes of human serum.
La Du BN; Eckerson HW
Fed Proc; 1984 May; 43(8):2338-41. PubMed ID: 6325253
[TBL] [Abstract][Full Text] [Related]
19. Interethnic differences in the detoxification of organophosphates: the human serum paraoxonase polymorphism.
Diepgen TL; Geldmacher-von Mallinckrodt M
Arch Toxicol Suppl; 1986; 9():154-8. PubMed ID: 3028323
[TBL] [Abstract][Full Text] [Related]
20. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
